Anónimo. Strontium ranelate discontinued. Prescribing Advice for GPs 2017:1. [Ref.ID 101637]

Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernández-Díaz S. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 2017;376:2245-54. [Ref.ID 101629]

Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff V, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom M, Corrao G, on behalf of the Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ 2016;354:i4857. [Ref.ID 100756]

Gislason GH, Torp-Pedersen C. NSAIDs and the failing heart. BMJ 2016;354:i5163. [Ref.ID 100755]

Renoux C, Dell'Aniello S, Khairy P, Marras C, Bugden S, Turin TC, Blais L, Tamim H, Evans C, Steele R, Dormuth C, Ernst P, the Canadian Network for Observational Drug Effect Studies (CNODES) investigators. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease. Br J Clin Pharmacol 2016;82:461-72. [Ref.ID 100688]

Anónimo. Riesgo de hipertensión arterial por mirabegrón. Butlletí de Farmacovigilància de Catalunya 2015;13:13-4. [Ref.ID 99832]

Anónimo. Riesgo de bradicardia grave con el uso concomitante de amiodarona y los nuevos antivíricos para la hepatitis C. Butlletí de Farmacovigilància de Catalunya 2015;13:5-7. [Ref.ID 99830]

Anónimo. Pazopanib: épanchements péricardiques. Prescrire 2014;34:511. [Ref.ID 98072]

Wise J. Benefits of trastuzumab outweight its harms, says Cochrane review. BMJ 2014;348:g3835. [Ref.ID 98034]

Sibiude J, Mandelbrot L, Blanche S, Le Chenadec J, Boullag-Bonnet N, Faye A, Dollfus C, Tubiana R, Bonnet D, Lelong N, Khoshnood B, Warszawski J. Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French Perinatal Cohort Study (ANRS CO1/CO11). PLOS Medicine 2014;11:1001635. [Ref.ID 97536]

Voon V, Saiva L, O'Kelly S, Keane D. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis – insights into possible drug mechanism. Eur J Clin Pharmacol 2014;70:373-5. [Ref.ID 97280]

Källén B, Danielsson BR. Fetal safety of erythromycin. An update of Swedish data. Eur J Clin Pharmacol 2014;70:355-60. [Ref.ID 97279]

Anónimo. Prégabaline: des effets indésirables cardiaques. Prescrire 2013;33:830. [Ref.ID 96728]

Jin J. FDA advisory panel recommends approval of drug for preoperative treatment of breast cancer. JAMA 2013;310:1434. [Ref.ID 96359]

Shah RR, Morganroth J, Shah DR. Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval). Drug Saf 2013;36:295-316. [Ref.ID 95517]

Cooke MJ, Waring WS. Citalopram and cardiac toxicity. Eur J Clin Pharmacol 2013;69:755-60. [Ref.ID 95191]

Anónimo. Ranelato de estroncio (Osseor, Protelos): riesgo de infarto agudo de miocardio. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2013:16 de abril. [Ref.ID 95186]

Anónimo. Seguridad de medicamentos: señales y alertas generadas en 2011-2012. Infac: Información Farmacoterapéutica de la Comarca 2013;21:1-9. [Ref.ID 95177]

Anónimo. Supplémentation en calcium: risques cardiovasculaires?. Prescrire 2013;33:190-1. [Ref.ID 95027]

Saiz Fernández LC. Atentos al déficit de atención (TDAH). Entre la naturaleza incierta y la prescripción hiperactiva. Boletín de Información Farmacoterapéutica de Navarra 2013;21:1-19. [Ref.ID 94628]